Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Carolyn M. Laurencot"'
Autor:
Steven A. Rosenberg, Carolyn M. Laurencot, Donald E. White, Kathleen E. Morton, Daniel A. Zlott, Russell C. Langan, Jenny J. Hong, Peter A. Prieto, John R. Wunderlich, Nicholas P. Restifo, Deborah E. Citrin, Marybeth S. Hughes, Udai S. Kammula, Giao Q. Phan, James C. Yang, Richard M. Sherry, Marcos R. Garcia, Michelle M. Langhan, Colin A. Gross, Mark E. Dudley
Supplementary Figure S1; Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f94fb798be3e5d1e9f601a5d4dba52
https://doi.org/10.1158/1078-0432.22442954
https://doi.org/10.1158/1078-0432.22442954
Autor:
Mark E. Dudley, Donald E. White, Seth M. Steinberg, Carolyn M. Laurencot, Kathleen E. Morton, John R. Wunderlich, Paul F. Robbins, Nicholas P. Restifo, Deborah E. Citrin, Giao Q. Phan, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, James C. Yang, Steven A. Rosenberg
CCR Translation for This Article from Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b6b475f50a620c2c70475bef1ea8b7
https://doi.org/10.1158/1078-0432.22442862
https://doi.org/10.1158/1078-0432.22442862
Autor:
Mark E. Dudley, Donald E. White, Seth M. Steinberg, Carolyn M. Laurencot, Kathleen E. Morton, John R. Wunderlich, Paul F. Robbins, Nicholas P. Restifo, Deborah E. Citrin, Giao Q. Phan, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, James C. Yang, Steven A. Rosenberg
Supplementary Figures S1-S2; Supplementary Tables S1-S2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5998d27ca7481193ba68975d894c7015
https://doi.org/10.1158/1078-0432.22442859.v1
https://doi.org/10.1158/1078-0432.22442859.v1
Autor:
Steven A. Rosenberg, Carolyn M. Laurencot, Donald E. White, Kathleen E. Morton, Daniel A. Zlott, Russell C. Langan, Jenny J. Hong, Peter A. Prieto, John R. Wunderlich, Nicholas P. Restifo, Deborah E. Citrin, Marybeth S. Hughes, Udai S. Kammula, Giao Q. Phan, James C. Yang, Richard M. Sherry, Marcos R. Garcia, Michelle M. Langhan, Colin A. Gross, Mark E. Dudley
Purpose: Tumor‐infiltrating lymphocytes (TIL) and interleukin (IL)-2 administered following lymphodepletion can cause the durable complete regression of bulky metastatic melanoma in patients refractory to approved treatments. However, the generatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::009bd66d72b8f448ebf39ad2c901b465
https://doi.org/10.1158/1078-0432.c.6519572.v1
https://doi.org/10.1158/1078-0432.c.6519572.v1
Autor:
Mark E. Dudley, Donald E. White, Seth M. Steinberg, Carolyn M. Laurencot, Kathleen E. Morton, John R. Wunderlich, Paul F. Robbins, Nicholas P. Restifo, Deborah E. Citrin, Giao Q. Phan, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, James C. Yang, Steven A. Rosenberg
Purpose: Most treatments for patients with metastatic melanoma have a low rate of complete regression and thus overall survival in these patients is poor. We investigated the ability of adoptive cell transfer utilizing autologous tumor-infiltrating l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3c1af0b460a79eeed604dda8e04a73a
https://doi.org/10.1158/1078-0432.c.6519510
https://doi.org/10.1158/1078-0432.c.6519510
Publikováno v:
Journal of Trauma and Acute Care Surgery. 81:S81-S86
Autor:
Robert T. Bailer, Maria Burgos Florez, Lucio Gama, Sung-Youl Ko, Zonghui Hu, Cynthia S. Hendel, Ro Shauna S Rothwell, Amarendra Pegu, Lily Zhang, Brenda Larkin, Katherine V. Houser, Jennifer Cunningham, Martin R. Gaudinski, Olga Vasilenko, Sandra Sitar, Julie E. Ledgerwood, Nicole A. Doria-Rose, Kathy Zephir, Preeti Apte, KC Cheng, William Whalen, Renunda Hicks, Richard A. Koup, Margarita M. Gomez Lorenzo, Floreliz Mendoza, Xiaolin Wang, Cristina Carter, LaSonji A. Holman, Young Do Kwon, Frank J. Arnold, Hope DeCederfelt, Grace L. Chen, Aryan M. Namboodiri, Peter D. Kwong, Kevin Carlton, Adrian B. McDermott, Joseph P. Casazza, Bob C. Lin, Nina M. Berkowitz, Nilusha Jayasinghe, Laura Novik, Catina R. Boyd, Edmund V. Capparelli, Carol Levinson, Galina Yamshchikov, Cora Trelles Cartagena, Carolyn M. Laurencot, Jason G. D. Gall, Michelle Conan-Cibotti, Sarah H. Plummer, Yunda Huang, Abidemi Ola, Pamela Costner, Ingelise J. Gordon, Janardan P. Pandey, Richard M. Schwartz, Judy Stein, Pernell Williams, Florence Kaltovich, Jamie G. Saunders, Iris Pittman, Milalynn Victorino, John R. Mascola, Barney S. Graham
Publikováno v:
The lancet. HIV. 6(10)
Summary Background Human monoclonal antibodies that potently and broadly neutralise HIV-1 are under development to prevent and treat HIV-1 infection. In this phase 1 clinical trial we aimed to determine the safety, tolerability, and pharmacokinetic p
Autor:
Udai S. Kammula, Richard M. Sherry, Mark E. Dudley, Richard A. Morgan, Steven A. Rosenberg, Wyndham H. Wilson, Steven A. Feldman, Carolyn M. Laurencot, James N. Kochenderfer, Michael S. Hughes, Giao Q. Phan, Irina Maric, Debbie Ann N. Nathan, David Spaner, Laura Devillier, Maryalice Stetler-Stevenson, Robert J. Carpenter, James Chih-Hsin Yang
Publikováno v:
Blood. 119:2709-2720
We conducted a clinical trial to assess adoptive transfer of T cells genetically modified to express an anti-CD19 chimeric Ag receptor (CAR). Our clinical protocol consisted of chemotherapy followed by an infusion of anti–CD19-CAR–transduced T ce
Autor:
Carolyn M. Laurencot, Udai S. Kammula, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Donald E. White, Steven A. Rosenberg, Kathleen E. Morton, James Chih-Hsin Yang, Michael S. Hughes, Deborah Citrin, Paul F. Robbins, Giao Q. Phan, Nicholas P. Restifo, Seth M. Steinberg
Publikováno v:
Clinical Cancer Research. 17:4550-4557
Purpose: Most treatments for patients with metastatic melanoma have a low rate of complete regression and thus overall survival in these patients is poor. We investigated the ability of adoptive cell transfer utilizing autologous tumor-infiltrating l
Autor:
Franz O. Smith, Richard E. Royal, Nicholas P. Restifo, Deborah Citrin, Udai S. Kammula, Susan F. Leitman, Kathleen E. Morton, Michael S. Hughes, Paul F. Robbins, Carolyn M. Laurencot, Richard M. Sherry, Stephanie G. Downey, Steven A. Rosenberg, John R. Wunderlich, Mark E. Dudley, Donald E. White, Jian Ping Huang, Jacob A. Klapper, Armen A. Thomasian, James Chih-Hsin Yang
Publikováno v:
Journal of Clinical Oncology. 26:5233-5239
Purpose The two approved treatments for patients with metastatic melanoma, interleukin (IL)-2 and dacarbazine, mediate objective response rates of 12% to 15%. We previously reported that adoptive cell therapy (ACT) with autologous antitumor lymphocyt